Locations
United States · Missoula, MT, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2016
Inimmune is a clinical-stage biotech company focused on the discovery and development of innovative immunotherapies for cancer, allergy, and autoimmune diseases. Their pipeline includes two clinical-stage Toll-like receptor (TLR) agonists and several pre-clinical programs aimed at creating next-generation vaccine adjuvants. Founded by experienced pharmaceutical professionals, Inimmune leverages extensive expertise in immunology and drug formulation to drive their innovative therapies forward, aiming to make meaningful clinical impacts in human health.
Something looks off?On-site & Remote